VHCP Management’s Stemline Therapeutics, Inc. STML Stock Holding History

VHCP Management’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.45M	Hold	135,420	–	–	1.56%	14
2016 Q3	$1.47M	Hold	135,420	–	–	1.44%	15
2016 Q2	$917K	Hold	135,420	–	–	0.95%	19
2016 Q1	$631K	Hold	135,420	–	–	0.55%	21
2015 Q4	$855K	Sell	135,420 -315,980	-70%	-$2.56M	0.52%	21
2015 Q3	$3.99M	Hold	451,400	–	–	1.02%	17
2015 Q2	$5.31M	Hold	451,400	–	–	1.5%	15
2015 Q1	$6.53M	Buy	451,400 +95,000	+27%	+$1.45M	1.5%	14
2014 Q4	$6.08M	Buy	356,400 +285,400	+402%	+$4.12M	1.67%	13
2014 Q3	$884K	Buy	+71,000	New	+$874K	0.4%	17
2013 Q3	–	Sell	-50,000	Closed	-$1.19M	–	19
2013 Q2	$1.19M	Buy	+50,000	New	+$796K	0.89%	16

Other funds holding STML

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

VHCP Management's STML Position: Q4 2016 in Review

VHCP Management held its Stemline Therapeutics, Inc. (STML) position steady in Q4 2016 at 135,420 shares worth $1.45M. The position accounts for 1.56% of the portfolio, ranked #14.

VHCP Management first reported a position in STML in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.53M in Q1 2015. 74 funds tracked by Wall St. Rank hold STML as of Q4 2016.

VHCP Management held 135,420 shares of Stemline Therapeutics, Inc. worth $1.45M as of Q4 2016.
VHCP Management left its Stemline Therapeutics, Inc. share count unchanged in Q4 2016.
Stemline Therapeutics, Inc. made up 1.56% of VHCP Management's portfolio in Q4 2016, its #14 holding.
VHCP Management first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and has held it in 11 quarters since.
VHCP Management's Stemline Therapeutics, Inc. position peaked at $6.53M in Q1 2015.
74 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.